GlassScriptPhysician profile
Julie Vaughn
NPI 1932177201
$839.97
in general payments reported to CMS, 2019-2025
17 companies · $51.36 in 2025
The $51.36 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $241 · 2021: $287 · 2022: $72.47 · 2025: $51.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $133.08 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $123.08 | 2020-2022 | |
| Lilly USA, LLC | $118.49 | 2019-2021 | |
| Allergan, INC. | $93.08 | 2019-2020 | |
| Abbvie INC. | $73.59 | 2021 | |
| Horizon Therapeutics Plc | $44.96 | 2021-2022 | |
| Esperion Therapeutics, INC. | $42.15 | 2021 | |
| Exact Sciences Corporation | $34.41 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.13 | 2019-2021 | |
| Pfizer INC. | $28.06 | 2019 | |
| Alexion Pharmaceuticals, INC. | $22.34 | 2020 | |
| Assertio Therapeutics, INC. | $20.32 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.95 | 2025 | Lifevest |
| Hikma Pharmaceuticals USA | $16.84 | 2021 | |
| Dynavax Technologies Corporation | $15.73 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.56 | 2021 | |
| Merck Sharp & Dohme LLC | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Vaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.